19-17555882-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_024656.4(COLGALT1):āc.169G>Cā(p.Ala57Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000195 in 1,387,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_024656.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COLGALT1 | NM_024656.4 | c.169G>C | p.Ala57Pro | missense_variant | 1/12 | ENST00000252599.9 | NP_078932.2 | |
COLGALT1 | XM_005260080.5 | c.-654G>C | upstream_gene_variant | XP_005260137.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COLGALT1 | ENST00000252599.9 | c.169G>C | p.Ala57Pro | missense_variant | 1/12 | 1 | NM_024656.4 | ENSP00000252599.3 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152020Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000210 AC: 26AN: 1235566Hom.: 0 Cov.: 33 AF XY: 0.0000182 AC XY: 11AN XY: 604646
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152020Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74252
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.169G>C (p.A57P) alteration is located in exon 1 (coding exon 1) of the COLGALT1 gene. This alteration results from a G to C substitution at nucleotide position 169, causing the alanine (A) at amino acid position 57 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at